Results 1 to 10 of about 860,012 (263)

Estimating the Loss in Expectation of Life and Relative Survival Rate among Hemodialysis Patients in Iran [PDF]

Journal of Research in Health Sciences, 2020
Information regarding the prognosis and burden of diseases can be used by policymakers to determine competing health priorities. We aimed to assess the Relative Survival Rate (RSR) and loss of expectation of life (LEL) to evaluate the prognosis and burden of diseases in Hemodialysis (HD) patients.A retrospective cohort study.We recruited 648 HD ...
Seyedghasemi, NS, Bahrampour, A, Etminan, A, Haghdoost, A, Baneshi, MR   +4 more
openaire   +6 more sources

A global review and perspective on prostate cancer survival: findings from survival studies of cancer registration data [PDF]

Journal of the National Cancer Center
Background: To better understand global status, temporal trends, and geographic disparities of prostate cancer survival, we systematically collected published survival studies on prostate cancer from cancer registries worldwide.
Yuxin Zhou, Yixin Zou, Qiuming Shen, Zhuoying Li, Yuting Tan, Honglan Li, Yongbing Xiang   +6 more
doaj   +2 more sources

Hepatocellular carcinoma risk, net survival and relative survival ratio in a high-income country of the Eastern Mediterranean Region: 2008–2020 [PDF]

BMC Gastroenterology
Background This cross-sectional cohort study aimed to estimate the incidence of hepatocellular carcinoma (HCC) and evaluate population-based net survival (NS) and relative survival ratios (RSR) among HCC patients in Kuwait.
Saeed Akhtar, Shaimaa Almohaid
doaj   +2 more sources

Recent estimates and predictions of 5-year survival rate in patients with pancreatic cancer: A model-based period analysis

Frontiers in Medicine, 2022
BackgroundThe 5-year survival rate for pancreatic cancer (PC) is incredibly low, resulting in this often being a fatal disease. Timely and accurate assessment of the survival rate and prognosis of patients with PC is of great significance for the ...
Jing Li, Jing Li, Yunmei Li, Chong Chen, Chong Chen, Jiayu Guo, Jiayu Guo, Mengmeng Qiao, Mengmeng Qiao, Jun Lyu, Jun Lyu   +10 more
doaj   +1 more source

Analysis and prediction of 5-year survival in patients with cutaneous melanoma: a model-based period analysis

Frontiers in Endocrinology, 2023
BackgroundThe survival and prognosis of patients are significantly threatened by cutaneous melanoma (CM), which is a highly aggressive disease. It is therefore crucial to determine the most recent survival rate of CM.
Suzheng Zheng, Hai Yu, Xinkai Zheng, U Tim Wu, Wai-kit Ming, Hui Huang, Jiaxin Song, Xiaoxi Zhang, Jun Lyu, Jun Lyu, Liehua Deng, Liehua Deng   +11 more
doaj   +1 more source

Analysis and prediction of relative survival trends in patients with non-Hodgkin lymphoma in the United States using a model-based period analysis method

Frontiers in Oncology, 2022
BackgroundSurvival rates are usually used to evaluate the effect of cancer treatment and prevention. This study aims to analyze the 5-year relative survival of non-Hodgkin lymphoma (NHL) in United States using population-based cancer registry data ...
Shuping Xie, Shuping Xie, Zhong Yu, Aozi Feng, Shuai Zheng, Yunmei Li, You Zeng, Jun Lyu, Jun Lyu   +8 more
doaj   +1 more source

5-YEAR RELATIVE SURVIVAL RATE BETWEEN SEMINOMA AND NON-SEMINOMA TESTICULAR CANCER IN SINGLE CENTER

Jurnal Urologi Indonesia, 2023
Objective: This study was conducted to provide data about the survival rate of testicular cancer patients with different histology in the year 2013 – 2017 in Adam Malik General Hospital and to compare these estimates with other studies conducted in ...
Ben Julian Mantiri, Ginanda Putra Siregar, Syah Mirsya Warli   +2 more
doaj   +1 more source

Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up

Breast, 2021
Background: Invasive lobular carcinoma (ILC) comprises 8–15 % of all invasive breast cancers and large population-based studies with >10 years of follow-up are rare. Whether ILC has a long-time prognosis different from that of invasive ductal carcinoma, (
C. Chamalidou, H. Fohlin, P. Albertsson, L.-G. Arnesson, Z. Einbeigi, E. Holmberg, A. Nordenskjöld, B. Nordenskjöld, P. Karlsson, B. Linderholm   +9 more
doaj   +1 more source

Incidence, mortality and survival analysis of small intestine cancer in Shanghai population-based study from 2002 to 2016 [PDF]

Waike lilun yu shijian, 2023
Objective: To investigate the incidence, mortality and survival of small intestine cancer in Shanghai from 2002 to 2016. Methods: Data of new small intestine cancer cases and deaths from 2002 to 2016 were obtained from the population-based cancer ...
WU Chunxiao, GU Kai, PANG Yi, WANG Chunfang, SHI Liang, XIANG Yongmei, GONG Yangming, DOU Jianming, SHI Yan, FU Chen
doaj   +1 more source

Recent survival trends in diffuse large B‐cell lymphoma––Have we made any progress beyond rituximab?

Cancer Medicine, 2020
Background Population‐based studies previously showed an improvement in overall survival (OS) for patients with diffuse large B‐cell lymphoma (DLBCL) who received chemoimmunotherapy with rituximab.
Narendranath Epperla, John L. Vaughn, Megan Othus, Abrahao Hallack, Luciano J. Costa   +4 more
doaj   +1 more source